Zobrazeno 1 - 10
of 2 072
pro vyhledávání: ''
Autor:
Yoshiaki Murakami, Shingo Seo, Hiroyuki Otsuka, Yasushi Hashimoto, Naru Kondo, Shinya Takahashi, Takeshi Sudo, Kenjiro Okada, Tatsuaki Sumiyoshi, Kenichiro Uemura
Publikováno v:
European Journal of Cancer. 159:215-223
Background The prognosis of patients with borderline resectable pancreatic cancer with arterial contact (BRPC-A) is extremely poor, and effective preoperative treatment is indispensable. We evaluated the clinical efficacy and safety of neoadjuvant ch
Autor:
Ina M. Jürgenliemk-Schulz, Elsbieta M. van der Steen-Banasik, Remi A. Nout, Jannet C. Beukema, Max Peters, Baukelien van Triest, Petronella O. Witteveen, Carien L. Creutzberg, Joanne A. de Hullu, Ludy C.H.W. Lutgens, Jacobus van der Velden, Henrike Westerveld, Marnix J.A. Rasing, An Snyers
Publikováno v:
Gynecologic Oncology, 163(1), 117-124. Academic Press
Gynecologic oncology, 163(1), 117-124. Academic Press Inc.
Gynecologic Oncology, 163, 1, pp. 117-124
Gynecologic Oncology, 163, 117-124
Gynecologic Oncology, 163(1), 117-124. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic oncology, 163(1), 117-124. Academic Press Inc.
Gynecologic Oncology, 163, 1, pp. 117-124
Gynecologic Oncology, 163, 117-124
Gynecologic Oncology, 163(1), 117-124. ACADEMIC PRESS INC ELSEVIER SCIENCE
Objective. To evaluate feasibility of chemoradiation as alternative for extensive surgery in patients with locally advanced vulvar cancer and to report on locoregional control, toxicity and survival. Methods. In a multicenter, prospective phase II tr
Autor:
Robert Peric, Vincent van der Noort, Harry J.M. Groen, Anne-Marie C. Dingemans, Nico van Walree, Franz M.N.H. Schramel, Christi M.J. Steendam, Pepijn Brocken, Stijn L.W. Koolen, G.D. Marijn Veerman, John W. G. van Putten, Ron H.J. Mathijssen, Egbert F. Smit, Joachim G.J.V. Aerts, Magdolen Youssef
Publikováno v:
Lung Cancer, 160, 44-49. Elsevier Ireland Ltd
Lung Cancer, 160, 44-49. ELSEVIER IRELAND LTD
Lung Cancer, 160, 44-49. ELSEVIER IRELAND LTD
Background: Earlier preclinical and phase II research showed enhanced effect of docetaxel plus intercalated erlotinib. The NVALT-18 phase III study was designed to compare docetaxel with docetaxel plus intercalated erlotinib in relapsed metastasized
Autor:
Yen-Cheng Chen, Cheng-Jen Ma, Ching-Chun Li, Wei-Chih Su, Po-Jung Chen, Tian-Lu Cheng, Tzu-Chieh Yin, Ching-Wen Huang, Tsung-Kun Chang, Hsiang-Lin Tsai, Kuo-Hsiang Chuang, Jaw-Yuan Wang
Publikováno v:
Oncology Research
Irinotecan, a topoisomerase inhibitor, is a common cytotoxic agent prescribed for metastatic colorectal cancer (mCRC) patients. Diarrhea is the most common adverse event (AE). The underlying mechanism of irinotecan-induced diarrhea is intestinal muco
Autor:
Dagmar Führer, Sarah Theurer, Harald Lahner, Nicole Unger, Kurt Werner Schmid, Jens M. Theysohn, Jan Rekowski, Annie Mathew, Karl-Heinz Jöckel, Ken Herrmann, Anna Lisa Klocker
Publikováno v:
Endocrine
Purpose The role of streptozocin-based chemotherapy (STZ CTx) in advanced, well-differentiated pancreatic neuroendocrine tumours (PanNET) and the best sequence of treatments in advanced PanNET are unclear. We examined the outcomes after STZ CTx in pa
Autor:
Clémence Breton, Jean-Baptiste Bachet, Jaafar Bennouna, Sylvain Manfredi, Jean-Louis Legoux, Aimery de Gramont, Karine Le Malicot, Thomas Aparicio, Thierry Lecomte, Olivier Bouché, Michel Ducreux, Olayidé Boussari, Julien Taieb, Jean-Marc Gornet
Publikováno v:
European Journal of Cancer. 153:40-50
Few studies have explored the association between baseline characteristics and the occurrence of early toxicities in patients treated with first-line chemotherapy for metastatic colorectal cancer (mCRC).Individual patient data of 2190 patients enroll
Autor:
Adity Chakraborty, Shibashis Deb, Amlan Jyoti Nath, Abhinandan Bhattacharjee, Aakanksha Rathor
Publikováno v:
The Egyptian Journal of Otolaryngology, Vol 37, Iss 1, Pp 1-9 (2021)
BackgroundCisplatin is a frontline anticancer drug routinely used as part of concurrent chemoradiation administered at 3-weekly (100 mg/m2) dose. However, its role as fractionated weekly dose has achieved favorable outcome in patients with locally ad
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 14, Iss 2, Pp 972-976 (2021)
Case Reports in Oncology, Vol 14, Iss 2, Pp 972-976 (2021)
We report on a 75-year old man who presented with metastatic, squamous-cell carcinoma (SCC) of the penis whose disease had progressed after radiotherapy (RT) and cisplatin-based chemotherapy (CT). A strong PD-L1 expression as well as a CDKN2A mutatio
Publikováno v:
Oncologist
Background Irinotecan (CPT11) is an important drug for small cell lung cancer (SCLC) chemotherapy (CTx). UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphisms can influence CPT11-related toxicity. This study aimed to assess prevalence of UGT1A1 poly
Publikováno v:
Cancer Management and Research
Jiwei Li,1– 3 Jin Li,4,5 Meizuo Zhong,6 Hui Zhou,4,5 Baohua Yu1– 3 1Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, People’s Republic of China; 2Department of Oncology, Shanghai Medical College, Fudan Univers